Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial

Szydlo, 1997, Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings, J Clin Oncol, 15, 1767, 10.1200/JCO.1997.15.5.1767 Beatty, 1985, Marrow transplantation from related donors other than HLA-identical siblings, N Engl J Med, 313, 765, 10.1056/NEJM198509263131301 Aversa, 2005, Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse, J Clin Oncol, 23, 3447, 10.1200/JCO.2005.09.117 Aversa, 2008, Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States, Bone Marrow Transplant, 41, 473, 10.1038/sj.bmt.1705966 Luznik, 2008, HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide, Biol Blood Marrow Transplant, 14, 641, 10.1016/j.bbmt.2008.03.005 Alyea, 2006, Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome, Biol Blood Marrow Transplant, 12, 1047, 10.1016/j.bbmt.2006.06.003 2005, Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials, J Clin Oncol, 23, 5074, 10.1200/JCO.2005.09.020 Przepiorka, 1995, 1994 Consensus Conference on Acute GVHD Grading, Bone Marrow Transplant, 15, 825 Filipovich, 2005, National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report, Biol Blood Marrow Transplant, 11, 945, 10.1016/j.bbmt.2005.09.004 Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Klein, 2001, Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 1: unadjusted analysis, Bone Marrow Transplant, 28, 909, 10.1038/sj.bmt.1703260 Di Ianni, 2011, Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation, Blood, 117, 3921, 10.1182/blood-2010-10-311894 Amrolia, 2006, Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation, Blood, 108, 1797, 10.1182/blood-2006-02-001909 Huang, 2006, Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies, Bone Marrow Transplant, 38, 291, 10.1038/sj.bmt.1705445 Grosso, 2011, A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing, Blood, 118, 4732, 10.1182/blood-2011-07-365338 Luznik, 2001, Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide, Blood, 98, 3456, 10.1182/blood.V98.12.3456 Schwartz, 1959, Drug-induced immunological tolerance, Nature, 183, 1682, 10.1038/1831682a0 Dominietto, 2011, Rapid immune reconstitution following unmanipulated haploidentical BMT with post-transplant high dose cyclophosphamide, Blood, 10.1182/blood.V118.21.3050.3050 Silva Lde, 2010, Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type, Haematologica, 95, 1183, 10.3324/haematol.2009.016758 Trotman, 1999, Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration, Bone Marrow Transplant, 23, 797, 10.1038/sj.bmt.1701644 Seber, 1999, Risk factors for severe hemorrhagic cystitis following BMT, Bone Marrow Transplant, 23, 35, 10.1038/sj.bmt.1701523 Yaghobi, 2009, The role of different risk factors in clinical presentation of hemorrhagic cystitis in hematopoietic stem cell transplant recipients, Transplant Proc, 41, 2900, 10.1016/j.transproceed.2009.07.060 Ogawa, 2006, Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning, Biol Blood Marrow Transplant, 12, 1073, 10.1016/j.bbmt.2006.06.007 Lu, 2006, Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation, Blood, 107, 3065, 10.1182/blood-2005-05-2146 Kröger, 2001, Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients, Bone Marrow Transplant, 27, 349, 10.1038/sj.bmt.1702802 Ringdén, 1999, Blood, 93, 2196, 10.1182/blood.V93.7.2196